Supply Issues Baxter Healthcare Limited Administration Set Gravity Burette FKA002 (ICN 3543)

Change:

• The supplier Baxter Healthcare Limited has informed us of a supply issue with its administration set gravity burette.
• There is one product affected:
  • FKA002 – Administration set gravity burette Gravity buretrol solution administration set 150 ml burette with ball valve vented spike chamber (60dpm).
• The supply issue is due to raw material shortage.

Impact:

• FKA002 is currently suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • FSB659 – Administration set gravity burette Gravity in-line buretrol solution administration set 150 ml burette non vented spike tube with protector 39.5cm
  • FSB672 – Administration set gravity burette Lifeshield Soluset 150ml Burette set with float valve 15u filter prepierced injection site prepierced Y site
  • FSB2298 – Administration sets for pump and gravity Colleague pumps Buretrol solution administration set 150 ml burette drip chamber 15micron filter.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 30 November 2026.

Next Steps:

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.